期刊文献+

去氧鬼臼毒素抑制肺癌NCI-H358细胞增殖和体外迁移的研究 被引量:5

Research on mechanisms of deoxypodophyllotoxin-induced inhibition of cell proliferation and migration in human lung cancer NCI-H358 cells
下载PDF
导出
摘要 目的探讨去氧鬼臼毒素对人肺癌NCI-H358细胞增殖和体外迁移的影响,并初步探讨其作用机制。方法应用CCK-8法、流式细胞术、细胞划痕实验和DCFH-D法分别检测去氧鬼臼毒素对NCI-H358细胞增殖、周期分布、凋亡、体外迁移能力和细胞内活性氧(ROS)的影响,并通过Western blot检测去氧鬼臼毒素对细胞周期蛋白(Cyclin)B1、细胞分裂周期蛋白25同源蛋白(Cdc25c)、细胞周期蛋白依赖性激酶(CDK)1、半胱氨酸天冬氨酸蛋白酶(Caspase)-3、p53肿瘤蛋白、B淋巴细胞瘤(Bcl)-2和基质金属蛋白酶(MMP)9的表达水平,以及细胞外信号调节激酶(ERK)1/2、p38分裂原激活蛋白激酶(MAPK)和c-Jun氨基末端激酶(JNK)的磷酸化水平的影响。结果去氧鬼臼毒素能明显抑制肺癌NCI-H358细胞的生长,流式细胞结果显示其能诱导细胞停滞在G2/M和S期,诱导细胞凋亡和细胞ROS产生,同时细胞体外迁移能力也明显下调。Western blot结果显示,去氧鬼臼毒素能使Cyclin B1、Cdc25c、CDK1、Bcl-2和MMP9的蛋白表达明显下调,而Caspase-3和p53的表达明显上调,且ERK1/2、p38MAPK和JNK的磷酸化水平明显受到抑制。结论去氧鬼臼毒素可抑制肺癌NCI-H358细胞的增殖和体外迁移,是一种潜在的抗肿瘤药物。 Objective To investigate the effects and mechanism of deoxypodophyllotoxin on cell proliferation and mi?gration of human lung cancer NCI-H358 cells in vitro. Methods CCK-8 assay, flow cytometry assay, wound healing assay and DCFH-DA assay were used to detect the effects of deoxypodophyllotoxin on the proliferation, cells cycle, apoptosis, mi?gration and reactive oxygen species (ROS). The protein expressions of Cyclin B1, Cdc25c, CDK1, Caspase-3, p53, Bcl-2, MMP9, ERK1/2, p38MAPK and JNK were measured by Western blot assay, respectively. Results Deoxypodophyllotoxin inhibited cell proliferation and reduced migration in human lung cancer NCI-H358 cells. Flow cytometry analysis showed that treatment with deoxypodophyllotoxin resulted in cell cycle G2/M and S phase arrest, cell apoptosis and ROS production. The result of Western blot assay showed that protein expressions of Cyclin B1, Cdc25c, CDK1, Bcl-2 and MMP9 were down-regulated while Caspase-3 and p53 were up-regulated. Moreover, Deoxypodophyllotoxin treatment decreased the phosphorylated levels of ERK1/2, p38MAPK and JNK obviously. Conclusion Deoxypodophyllotoxin could suppress the proliferation and migration of human lung cancer NCI-H358 cells in vitro, which is a potential anti-tumor drug.
出处 《天津医药》 CAS 2016年第5期568-572,共5页 Tianjin Medical Journal
关键词 鬼臼毒素 肺肿瘤 细胞增殖 细胞运动 去氧鬼臼毒素 podophyllotoxin lung neoplasms cell proliferation cell movement deoxypodophyllotoxin
  • 相关文献

参考文献1

二级参考文献14

  • 1Tsutsui M, Kawakubo H, Hayashida T, et al. Comprehensive screen- ing of genes resistant to an anticancer drug in esophageal squamous cell carcinoma[J]. Int J Oncol, 2015, 47(3):867-874.doi:10.3892/ ijo.2015.3085.
  • 2Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action[J].Eur J Pharmacol, 2014, 5(740):364-378. doi: 10.1016/j.ejphar.2014.07.025.
  • 3Liccardi G, Hartley JA, Hochhauser D. EGFR nuclear translocatioa modulates DNA repair following cisplatin and ionizing radiation treatment[J]. Cancer Res, 2011, 71(3):1103-1114. doi: 10.1158/0008-5472.CAN- 10-2384.
  • 4Wang W, Dai LX, Zhang S, et al. Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo [J].Neoplas- ma, 2013,60(3):274-283.doi: 10.4149/neo_2013_036.
  • 5Wang YN, Yamaguchi H, Hsu JM, et al. Nuclear trafficking of the epidermal growth factor receptor family membrane proteins[J]. J On- cogene, 2010, 29(25):3997-4006. doi: 10.1038/0nc.2010.157.
  • 6Huo L, Wang YN, Xia W, et al. RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus [J]. Proc Natl Acad Sci USA, 2010, 107(37):16125-16130. doi: 10.1073/pnas.1000743107.
  • 7Dittmann K, Mayer C, Fehrenbacher B, et al. Nuclear EGFR shut- tling induced by ionizing radiation is regulated by phosphorylation at residue Thr654[J]. FEBS Lett, 2010, 584(18):3878-3884.
  • 8Brand TM, Iida M, Luthar N, et al. Nuclear EGFR as a molecular target in cancer [J]. Radiother Oncol, 2013, 108(3):370-377. doi: 10.1016/i. radonc. 2013.06.010.
  • 9Kalinowski FC, Brown RA, Ganda C, et al. MicroRNA-7: a tumor suppressor miRNA with therapeutic potential[J].Int J Biochem Cell Biol, 2014,9(54):312-317. doi: 10.1016/j.biocel.2014.05.040.
  • 10Pogribny IP, Filkowski JN, Tryndyak VP,et al. Alterations of mi- croRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer ceils to cisplatin[J]. Int J Cancer, 2010, 127(8):1785-1794. doi: 10.1002/ijc.25191.

同被引文献40

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部